A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool

Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical virology 1999-02, Vol.57 (2), p.91-99
Hauptverfasser: Chudy, Michael, Budek, Irmhild, Keller-Stanislawski, Brigitte, McCaustland, Karen A., Neidhold, Sabine, Robertson, Betty H., Nübling, C. Micha, Seitz, Rainer, Löwer, Johannes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 99
container_issue 2
container_start_page 91
container_title Journal of medical virology
container_volume 57
creator Chudy, Michael
Budek, Irmhild
Keller-Stanislawski, Brigitte
McCaustland, Karen A.
Neidhold, Sabine
Robertson, Betty H.
Nübling, C. Micha
Seitz, Rainer
Löwer, Johannes
description Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak of hepatitis A in six hemophiliacs treated with the same lot of a factor VIII preparation occurred recently in Germany. The objective of the study was to clarify whether these diseases were caused by the administration of the S/D‐treated plasma product, rather than a community‐acquired infection. Polymerase chain reactions designed to detect HAV nucleic acid have been carried out in the implicated factor VIII lots, in the corresponding plasma pools, and in serum samples of four out of six infected individuals. The nucleic acid sequences were determined in samples that resulted in positive amplification products. HAV sequences were found in one of the two plasma pools used for manufacture of the incriminated product, in the incriminated lot itself, and in all recipient sera tested so far, although the latter were collected up to 7 weeks after the onset of jaundice. The sequences obtained were completely identical, revealing a unique HAV strain of genotype IA. This study provides conclusive evidence that hepatitis A can be transmitted by factor VIII concentrates treated solely by the S/D procedure for virus inactivation. This inactivation method is not effective against nonenveloped viruses. Since a number of hepatitis A transmission episodes have been described with such preparations during the past 10 years, their continued use seems to be questionable unless additional virus removal or inactivation steps are introduced to prevent the transmission of nonenveloped viruses. Molecular approaches again proved to be reliable tools for elucidating the chain of virus transmission. J. Med. Virol. 57:91–99, 1999. © 1999 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1096-9071(199902)57:2<91::AID-JMV1>3.0.CO;2-L
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69559137</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17148892</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4561-50076e12261bb8b267bc14cb432a8e24f6743769c37ff7765be880f3c26ea8e3</originalsourceid><addsrcrecordid>eNqFUk2P0zAQtRBoKYWfgOQDQruHFH8kdtxFSCXAblGXHlrBgcPI8TpaQxKHONWy_x6HVt0DCE4znnl68_SeETqnZEYJYa9ON8tieUaJEokikp5SpRRhZ5mcs9eKzueL5bvk49Vn-obPyKxYn7Nk9QBNjviHaEJoKhIhaPYYPQnhGyEkV4ydoBMVK1dkgr4ucGtvsal3YbA99hW-sZ0e3OACXmDXVtYMzrexi4vGdzeudtoEPPTa2Gs8eKyx8e2gG9fqIU66WodG4877-il6VOk62GeHOkXbD--3xWWyWl8si8UqMWkmaJIRIoWljAlalnnJhCwNTU2ZcqZzy9JKyJRLoQyXVSWlyEqb56TihgkbAXyKXu5pu97_2NkwQOOCsXWtW-t3AYTKMkW5_C-QSprmozFTtNkDTe9D6G0FXe8a3d8BJTBGAzBGA6PVMFoN-2ggk8BAUYAYDYzRAAcCxTpOV5H1-eH8rmzs9ZHzkEXcvzjsdTC6rnrdGhfuT4uUME7vxd262t79oezfwv6i6_c7siZ7Vhf_wc8jq-6_g5BcZvDl0wVsrxh7u1kxuOS_AFL3w4c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17148892</pqid></control><display><type>article</type><title>A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Chudy, Michael ; Budek, Irmhild ; Keller-Stanislawski, Brigitte ; McCaustland, Karen A. ; Neidhold, Sabine ; Robertson, Betty H. ; Nübling, C. Micha ; Seitz, Rainer ; Löwer, Johannes</creator><creatorcontrib>Chudy, Michael ; Budek, Irmhild ; Keller-Stanislawski, Brigitte ; McCaustland, Karen A. ; Neidhold, Sabine ; Robertson, Betty H. ; Nübling, C. Micha ; Seitz, Rainer ; Löwer, Johannes</creatorcontrib><description>Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak of hepatitis A in six hemophiliacs treated with the same lot of a factor VIII preparation occurred recently in Germany. The objective of the study was to clarify whether these diseases were caused by the administration of the S/D‐treated plasma product, rather than a community‐acquired infection. Polymerase chain reactions designed to detect HAV nucleic acid have been carried out in the implicated factor VIII lots, in the corresponding plasma pools, and in serum samples of four out of six infected individuals. The nucleic acid sequences were determined in samples that resulted in positive amplification products. HAV sequences were found in one of the two plasma pools used for manufacture of the incriminated product, in the incriminated lot itself, and in all recipient sera tested so far, although the latter were collected up to 7 weeks after the onset of jaundice. The sequences obtained were completely identical, revealing a unique HAV strain of genotype IA. This study provides conclusive evidence that hepatitis A can be transmitted by factor VIII concentrates treated solely by the S/D procedure for virus inactivation. This inactivation method is not effective against nonenveloped viruses. Since a number of hepatitis A transmission episodes have been described with such preparations during the past 10 years, their continued use seems to be questionable unless additional virus removal or inactivation steps are introduced to prevent the transmission of nonenveloped viruses. Molecular approaches again proved to be reliable tools for elucidating the chain of virus transmission. J. Med. Virol. 57:91–99, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0146-6615</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/(SICI)1096-9071(199902)57:2&lt;91::AID-JMV1&gt;3.0.CO;2-L</identifier><identifier>PMID: 9892390</identifier><identifier>CODEN: JMVIDB</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Biological and medical sciences ; Blood-Borne Pathogens - isolation &amp; purification ; Cluster Analysis ; Disease Outbreaks ; Factor VIII - adverse effects ; Genotype ; Germany ; HAV transmission ; Hemophilia A - complications ; Hemophilia A - virology ; Hepatitis A - complications ; Hepatitis A - epidemiology ; Hepatitis A - etiology ; Hepatitis A - virology ; Hepatitis A virus ; Hepatovirus - genetics ; Hepatovirus - isolation &amp; purification ; Human viral diseases ; Humans ; Infectious diseases ; Medical sciences ; Middle Aged ; nucleic acid sequence ; Phylogeny ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Viral - blood ; S/D-treated factor VIII ; Sequence Analysis, DNA ; Sequence Homology, Nucleic Acid ; Space life sciences ; Viral diseases ; Viral hepatitis ; Viral Proteins - genetics ; Viral Structural Proteins - genetics ; von Willebrand Diseases - complications ; von Willebrand Diseases - virology</subject><ispartof>Journal of medical virology, 1999-02, Vol.57 (2), p.91-99</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4561-50076e12261bb8b267bc14cb432a8e24f6743769c37ff7765be880f3c26ea8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C91%3A%3AAID-JMV1%3E3.0.CO%3B2-L$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C91%3A%3AAID-JMV1%3E3.0.CO%3B2-L$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1640231$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9892390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chudy, Michael</creatorcontrib><creatorcontrib>Budek, Irmhild</creatorcontrib><creatorcontrib>Keller-Stanislawski, Brigitte</creatorcontrib><creatorcontrib>McCaustland, Karen A.</creatorcontrib><creatorcontrib>Neidhold, Sabine</creatorcontrib><creatorcontrib>Robertson, Betty H.</creatorcontrib><creatorcontrib>Nübling, C. Micha</creatorcontrib><creatorcontrib>Seitz, Rainer</creatorcontrib><creatorcontrib>Löwer, Johannes</creatorcontrib><title>A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool</title><title>Journal of medical virology</title><addtitle>J. Med. Virol</addtitle><description>Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak of hepatitis A in six hemophiliacs treated with the same lot of a factor VIII preparation occurred recently in Germany. The objective of the study was to clarify whether these diseases were caused by the administration of the S/D‐treated plasma product, rather than a community‐acquired infection. Polymerase chain reactions designed to detect HAV nucleic acid have been carried out in the implicated factor VIII lots, in the corresponding plasma pools, and in serum samples of four out of six infected individuals. The nucleic acid sequences were determined in samples that resulted in positive amplification products. HAV sequences were found in one of the two plasma pools used for manufacture of the incriminated product, in the incriminated lot itself, and in all recipient sera tested so far, although the latter were collected up to 7 weeks after the onset of jaundice. The sequences obtained were completely identical, revealing a unique HAV strain of genotype IA. This study provides conclusive evidence that hepatitis A can be transmitted by factor VIII concentrates treated solely by the S/D procedure for virus inactivation. This inactivation method is not effective against nonenveloped viruses. Since a number of hepatitis A transmission episodes have been described with such preparations during the past 10 years, their continued use seems to be questionable unless additional virus removal or inactivation steps are introduced to prevent the transmission of nonenveloped viruses. Molecular approaches again proved to be reliable tools for elucidating the chain of virus transmission. J. Med. Virol. 57:91–99, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Blood-Borne Pathogens - isolation &amp; purification</subject><subject>Cluster Analysis</subject><subject>Disease Outbreaks</subject><subject>Factor VIII - adverse effects</subject><subject>Genotype</subject><subject>Germany</subject><subject>HAV transmission</subject><subject>Hemophilia A - complications</subject><subject>Hemophilia A - virology</subject><subject>Hepatitis A - complications</subject><subject>Hepatitis A - epidemiology</subject><subject>Hepatitis A - etiology</subject><subject>Hepatitis A - virology</subject><subject>Hepatitis A virus</subject><subject>Hepatovirus - genetics</subject><subject>Hepatovirus - isolation &amp; purification</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>nucleic acid sequence</subject><subject>Phylogeny</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Viral - blood</subject><subject>S/D-treated factor VIII</subject><subject>Sequence Analysis, DNA</subject><subject>Sequence Homology, Nucleic Acid</subject><subject>Space life sciences</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><subject>Viral Proteins - genetics</subject><subject>Viral Structural Proteins - genetics</subject><subject>von Willebrand Diseases - complications</subject><subject>von Willebrand Diseases - virology</subject><issn>0146-6615</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk2P0zAQtRBoKYWfgOQDQruHFH8kdtxFSCXAblGXHlrBgcPI8TpaQxKHONWy_x6HVt0DCE4znnl68_SeETqnZEYJYa9ON8tieUaJEokikp5SpRRhZ5mcs9eKzueL5bvk49Vn-obPyKxYn7Nk9QBNjviHaEJoKhIhaPYYPQnhGyEkV4ydoBMVK1dkgr4ucGtvsal3YbA99hW-sZ0e3OACXmDXVtYMzrexi4vGdzeudtoEPPTa2Gs8eKyx8e2gG9fqIU66WodG4877-il6VOk62GeHOkXbD--3xWWyWl8si8UqMWkmaJIRIoWljAlalnnJhCwNTU2ZcqZzy9JKyJRLoQyXVSWlyEqb56TihgkbAXyKXu5pu97_2NkwQOOCsXWtW-t3AYTKMkW5_C-QSprmozFTtNkDTe9D6G0FXe8a3d8BJTBGAzBGA6PVMFoN-2ggk8BAUYAYDYzRAAcCxTpOV5H1-eH8rmzs9ZHzkEXcvzjsdTC6rnrdGhfuT4uUME7vxd262t79oezfwv6i6_c7siZ7Vhf_wc8jq-6_g5BcZvDl0wVsrxh7u1kxuOS_AFL3w4c</recordid><startdate>199902</startdate><enddate>199902</enddate><creator>Chudy, Michael</creator><creator>Budek, Irmhild</creator><creator>Keller-Stanislawski, Brigitte</creator><creator>McCaustland, Karen A.</creator><creator>Neidhold, Sabine</creator><creator>Robertson, Betty H.</creator><creator>Nübling, C. Micha</creator><creator>Seitz, Rainer</creator><creator>Löwer, Johannes</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199902</creationdate><title>A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool</title><author>Chudy, Michael ; Budek, Irmhild ; Keller-Stanislawski, Brigitte ; McCaustland, Karen A. ; Neidhold, Sabine ; Robertson, Betty H. ; Nübling, C. Micha ; Seitz, Rainer ; Löwer, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4561-50076e12261bb8b267bc14cb432a8e24f6743769c37ff7765be880f3c26ea8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Blood-Borne Pathogens - isolation &amp; purification</topic><topic>Cluster Analysis</topic><topic>Disease Outbreaks</topic><topic>Factor VIII - adverse effects</topic><topic>Genotype</topic><topic>Germany</topic><topic>HAV transmission</topic><topic>Hemophilia A - complications</topic><topic>Hemophilia A - virology</topic><topic>Hepatitis A - complications</topic><topic>Hepatitis A - epidemiology</topic><topic>Hepatitis A - etiology</topic><topic>Hepatitis A - virology</topic><topic>Hepatitis A virus</topic><topic>Hepatovirus - genetics</topic><topic>Hepatovirus - isolation &amp; purification</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>nucleic acid sequence</topic><topic>Phylogeny</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Viral - blood</topic><topic>S/D-treated factor VIII</topic><topic>Sequence Analysis, DNA</topic><topic>Sequence Homology, Nucleic Acid</topic><topic>Space life sciences</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><topic>Viral Proteins - genetics</topic><topic>Viral Structural Proteins - genetics</topic><topic>von Willebrand Diseases - complications</topic><topic>von Willebrand Diseases - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chudy, Michael</creatorcontrib><creatorcontrib>Budek, Irmhild</creatorcontrib><creatorcontrib>Keller-Stanislawski, Brigitte</creatorcontrib><creatorcontrib>McCaustland, Karen A.</creatorcontrib><creatorcontrib>Neidhold, Sabine</creatorcontrib><creatorcontrib>Robertson, Betty H.</creatorcontrib><creatorcontrib>Nübling, C. Micha</creatorcontrib><creatorcontrib>Seitz, Rainer</creatorcontrib><creatorcontrib>Löwer, Johannes</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chudy, Michael</au><au>Budek, Irmhild</au><au>Keller-Stanislawski, Brigitte</au><au>McCaustland, Karen A.</au><au>Neidhold, Sabine</au><au>Robertson, Betty H.</au><au>Nübling, C. Micha</au><au>Seitz, Rainer</au><au>Löwer, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J. Med. Virol</addtitle><date>1999-02</date><risdate>1999</risdate><volume>57</volume><issue>2</issue><spage>91</spage><epage>99</epage><pages>91-99</pages><issn>0146-6615</issn><eissn>1096-9071</eissn><coden>JMVIDB</coden><abstract>Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak of hepatitis A in six hemophiliacs treated with the same lot of a factor VIII preparation occurred recently in Germany. The objective of the study was to clarify whether these diseases were caused by the administration of the S/D‐treated plasma product, rather than a community‐acquired infection. Polymerase chain reactions designed to detect HAV nucleic acid have been carried out in the implicated factor VIII lots, in the corresponding plasma pools, and in serum samples of four out of six infected individuals. The nucleic acid sequences were determined in samples that resulted in positive amplification products. HAV sequences were found in one of the two plasma pools used for manufacture of the incriminated product, in the incriminated lot itself, and in all recipient sera tested so far, although the latter were collected up to 7 weeks after the onset of jaundice. The sequences obtained were completely identical, revealing a unique HAV strain of genotype IA. This study provides conclusive evidence that hepatitis A can be transmitted by factor VIII concentrates treated solely by the S/D procedure for virus inactivation. This inactivation method is not effective against nonenveloped viruses. Since a number of hepatitis A transmission episodes have been described with such preparations during the past 10 years, their continued use seems to be questionable unless additional virus removal or inactivation steps are introduced to prevent the transmission of nonenveloped viruses. Molecular approaches again proved to be reliable tools for elucidating the chain of virus transmission. J. Med. Virol. 57:91–99, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>9892390</pmid><doi>10.1002/(SICI)1096-9071(199902)57:2&lt;91::AID-JMV1&gt;3.0.CO;2-L</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0146-6615
ispartof Journal of medical virology, 1999-02, Vol.57 (2), p.91-99
issn 0146-6615
1096-9071
language eng
recordid cdi_proquest_miscellaneous_69559137
source MEDLINE; Access via Wiley Online Library
subjects Adult
Biological and medical sciences
Blood-Borne Pathogens - isolation & purification
Cluster Analysis
Disease Outbreaks
Factor VIII - adverse effects
Genotype
Germany
HAV transmission
Hemophilia A - complications
Hemophilia A - virology
Hepatitis A - complications
Hepatitis A - epidemiology
Hepatitis A - etiology
Hepatitis A - virology
Hepatitis A virus
Hepatovirus - genetics
Hepatovirus - isolation & purification
Human viral diseases
Humans
Infectious diseases
Medical sciences
Middle Aged
nucleic acid sequence
Phylogeny
Reverse Transcriptase Polymerase Chain Reaction
RNA, Viral - blood
S/D-treated factor VIII
Sequence Analysis, DNA
Sequence Homology, Nucleic Acid
Space life sciences
Viral diseases
Viral hepatitis
Viral Proteins - genetics
Viral Structural Proteins - genetics
von Willebrand Diseases - complications
von Willebrand Diseases - virology
title A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T12%3A43%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20new%20cluster%20of%20hepatitis%20A%20infection%20in%20hemophiliacs%20traced%20to%20a%20contaminated%20plasma%20pool&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Chudy,%20Michael&rft.date=1999-02&rft.volume=57&rft.issue=2&rft.spage=91&rft.epage=99&rft.pages=91-99&rft.issn=0146-6615&rft.eissn=1096-9071&rft.coden=JMVIDB&rft_id=info:doi/10.1002/(SICI)1096-9071(199902)57:2%3C91::AID-JMV1%3E3.0.CO;2-L&rft_dat=%3Cproquest_cross%3E17148892%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17148892&rft_id=info:pmid/9892390&rfr_iscdi=true